Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
An activist's guide to TB drugs

TB treatment must be shorter, simpler, less toxic, and more tolerable and affordable. Activists can contribute to the development and uptake of improved TB treatment by calling attention to research, quality of medications, and access priorities.

Published
04 June 2014
From
TAG
In HIV/TB coinfection, raltegravir may be an alternative to efavirenz

Patients coinfected with HIV and tuberculosis (TB) may benefit from raltegravir as an alternative to efavirenz, new research suggests.

Published
02 June 2014
From
Medscape
TB drug approvals, distribution deal inches options forward, but MDR TB treatment access still uncertain where needed most

Last week’s important developments in TB treatment included the announcement that bedaquiline, the currently most promising medicine for multi-drug-resistant tuberculosis, will become available to patients in 130 low- and middle-income countries through the Stop TB Partnership’s Global Drug Facility.

Published
14 May 2014
From
Science Speaks
UNITAID approves grants of $160 million, for hepatitis C, MDR-TB and malaria drugs

Breakthrough new medicines for hepatitis C and drug-resistant TB and largest-yet global programme for seasonal malaria chemoprevention to be made available for low- and middle-income countries as part of $160 million of new grants funded by UNITAID

Published
07 May 2014
From
UNITAID
Lab-Confirmed HIV Rate 33% Among Kenyans With Prior Tuberculosis

Among Kenyans with prior tuberculosis, one third had lab-confirmed HIV infection, according to results of a nationally representative survey. Adult HIV prevalence stood at 5.6%.

Published
07 May 2014
From
International AIDS Society
Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)

First grant of a marketing authorization of Otsuka’s novel drug for multidrug-resistant tuberculosis (MDR-TB).

Published
01 May 2014
From
Otsuka press release
Antibiotic crisis bigger than Aids as common infections will kill, WHO warns

The report, Antimicrobial resistance: global report on surveillance focuses on antibiotic resistance in seven different bacteria responsible for common, serious diseases such as sepsis, diarrhoea, pneumonia, urinary tract infections and gonorrhoea.It found that antibiotic resistance is present in all areas of the globe and is growing.

Published
30 April 2014
From
Daily Telegraph
CROI 2014: Chronic lung disease is prevalent and under-diagnosed in people with HIV

Even though the incidence of most HIV-related respiratory complications and opportunistic infections have declined dramatically since the advent of effective antiretroviral therapy (ART), 4 studies presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) last month in Boston showed that people living with HIV are still at increased risk...

Published
28 April 2014
From
HIVandHepatitis.com
New and better drugs for MDR-TB on the horizon

A phase III trial of a novel combination of drugs for tuberculosis, including some drug-resistant strains, will launch within the year, the TB Alliance announced.

Published
24 April 2014
From
The Guardian
South Africa: ARV Programme Saves 780 000 Lives

South Africa's HIV antiretroviral treatment programme saved 780 000 lives between 2003 and 2012, according to a recently released independent review. But the tuberculosis programme is failing to meet targets.

Published
14 April 2014
From
Health-e

Filter by country